Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.

Related articles by Zemanta

• Different Strains of Theiler's Murine Encephalomyelitis Virus Antagonize Different Sites in the Type I Interferon Pathway [Pathogenesis and Immunity] (jvi.asm.org)
• Novartis Gets FDA Approval on First Oral Multiple Sclerosis Drug - Gilenya (ducknetweb.blogspot.com)